Medpace Holdings (MEDP) Free Cash Flow (2015 - 2026)

Medpace Holdings has reported Free Cash Flow for 12 years, with the latest figure at $145.0 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow rose 25.15% year-over-year to $145.0 million; the trailing twelve-month figure through Mar 2026 stood at $711.0 million (up 31.44% YoY), and the FY2025 full-year result was $681.9 million, up 19.15% from the prior year.
• Free Cash Flow for Q1 2026 stood at $145.0 million, down from $188.1 million in the prior quarter.
• The five-year high for Free Cash Flow was $235.5 million in Q3 2025, with the low at $37.0 million in Q1 2022.
• Historically, Free Cash Flow has averaged $126.3 million across 5 years, with a median of $127.4 million in 2022.
• Annual changes were most pronounced in 2022 — Free Cash Flow decreased 27.18% — and 2024, when it soared 108.58%.
• Medpace Holdings' Free Cash Flow stood at $127.4 million in 2022, then increased by 14.88% to $146.4 million in 2023, then rose by 25.01% to $183.0 million in 2024, then climbed by 2.78% to $188.1 million in 2025, then retreated by 22.93% to $145.0 million in 2026.
• The last three Free Cash Flow figures came in at $145.0 million (Q1 2026), $188.1 million (Q4 2025), and $235.5 million (Q3 2025), per Business Quant data.